Maria Dobrinas
- Co-authors
- Chin B. EapJacques CornuzBeatrice OnedaNicolas AnsermotMuriel NoetzliEva ChoongPierre‐Alain CarruptRubin Lubomirov
- Topics
- Pharmacogenetics and Drug Metabolism (4 papers)Pharmaceutical Practices and Patient Outcomes (4 papers)Glutathione Transferases and Polymorphisms (3 papers)
- Journals
- Human Molecular GeneticsClinical Pharmacology & TherapeuticsJournal of Pharmaceutical and Biomedical Analysis
- Partner nations
- SwitzerlandUnited StatesSpain
In The Last Decade
Maria Dobrinas
16 papers receiving 391 citations
Peers
Comparison fields: 5 of 97
- Pharmacology 122
- Pharmacology 87
- Molecular Biology 85
- Physiology 69
- Oncology 52
Countries citing papers authored by Maria Dobrinas
This map shows the geographic impact of Maria Dobrinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Dobrinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Dobrinas more than expected).
Fields of papers citing papers by Maria Dobrinas
This network shows the impact of papers produced by Maria Dobrinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Dobrinas. The network helps show where Maria Dobrinas may publish in the future.
Co-authorship network of co-authors of Maria Dobrinas
This figure shows the co-authorship network connecting the top 25 collaborators of Maria Dobrinas. A scholar is included among the top collaborators of Maria Dobrinas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Dobrinas. Maria Dobrinas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 2 | |
| 3 | 12 | |
| 4 | 11 | |
| 5 | 14 | |
| 6 | 13 | |
| 7 | 18 | |
| 8 | 48 | |
| 9 | 48 | |
| 10 | 39 | |
| 11 | 29 | |
| 12 | 13 | |
| 13 | 37 | |
| 14 | 90 | |
| 15 | 22 | |
| 16 | [Genetic aspects of smoking and impact on clinical care]. | 2 |
About Maria Dobrinas
Maria Dobrinas is a scholar working on Chemical Health and Safety, Geriatrics and Gerontology and Pharmacology, having authored 16 papers that have together received 401 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (4 papers), Pharmaceutical Practices and Patient Outcomes (4 papers) and Glutathione Transferases and Polymorphisms (3 papers). The work is most often cited by research in Pharmacology (122 citations), Geriatrics and Gerontology (26 citations) and Pharmacology (87 citations). Maria Dobrinas has collaborated with scholars based in Switzerland, United States and Spain. Frequent co-authors include Chin B. Eap, Jacques Cornuz, Beatrice Oneda, Nicolas Ansermot, Muriel Noetzli, Eva Choong, Pierre‐Alain Carrupt, Rubin Lubomirov, Chantal Csajka and Margalida Rotger. Their work appears in journals such as Human Molecular Genetics, Clinical Pharmacology & Therapeutics and Journal of Pharmaceutical and Biomedical Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.